| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5feb4a4d8a0f1c164feed988f4e4e42a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D339-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-072 |
| filingDate |
2014-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_586e04da23c33e4e302ecc2478e3baa7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3a4e02cf4150d76d24cad546575f166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bce16bf51962a0d922b1dc1702b57db8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20d91ce024739a3b707eca1dfa1fcf92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40f605d08101dd8b221e234046fcfc68 |
| publicationDate |
2014-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014274917-A1 |
| titleOfInvention |
Compositions and Methods for Treating Ischemia and Ischemia-Reperfusion Injury |
| abstract |
The present invention relates to compositions comprising a substantially pure compound represented by Structural Formula I: n n n n n n n n n n and methods of using such compounds to activate cytoprotective kinases. The values and preferred values of the variables in Structural Formula I are defined herein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11213509-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10744115-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9540417-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10531655-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9359325-B2 |
| priorityDate |
2009-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |